340B Drug Pricing Program
AHA, Others File Amicus Brief Challenging PhRMA in Defense of Louisiana's 340B Contract Pharmacy Law
AHA, Others File Amicus Brief Challenging PhRMA in Defense of Louisiana's 340B Contract Pharmacy Law.
AHA, Others File Amicus Brief Challenging AstraZeneca in Defense of Louisiana's 340B Contract Pharmacy Law.
The Administration releases executive order on drug pricing; read AHA’s statement.
A Minnesota state court April 15 dismissed a lawsuit filed by PhRMA challenging the state’s law protecting 340B pricing for contract pharmacy arrangements.
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
With your senators and representatives home in their states and districts for the next two weeks, please reach out to your lawmakers and urge them to reject funding cuts to Medicaid and other health care programs as part of reconciliation bill.
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed with the United States District Court for the District of Columbia.
The Department of Health and Human Services said its decision to prevent drug companies from implementing a 340B rebate model “was within its statutory authority,” according to a department brief filed March 17 with the United States District Court for the District of Columbia.
AHA 340B Advocacy Alliance Bulletin for March 13, 2025.
The 340B Drug Pricing Program helps ensure access to care for patients and communities most in need. A bipartisan effort by Congress in 1992 designed the program to protect hospitals from rising drug costs — a dynamic that continues to present major challenges today.